What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Virology, Virus, Antibody, Immunology and Viral envelope.
Dani P. Bolognesi does research in Virology, focusing on Neutralizing antibody specifically.
His Virus research integrates issues from Oncornavirus, Molecular biology and Molecular mass.
The concepts of his Molecular biology study are interwoven with issues in RNA and Viral protein.
The Antibody study combines topics in areas such as T cell and Cytolysis.
His Viral envelope research focuses on subjects like V3 loop, which are linked to Peptide and Simian immunodeficiency virus.
His most cited work include:
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. (1482 citations)
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. (1150 citations)
- POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY (944 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Virology, Virus, Antibody, Molecular biology and Immunology.
His Virology research is mostly focused on the topic Neutralization.
Dani P. Bolognesi has included themes like Cell culture, Antiserum and Cell in his Virus study.
His study in Cytolysis extends to Antibody with its themes.
His work investigates the relationship between Molecular biology and topics such as Biochemistry that intersect with problems in Gp41.
His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Acquired immunodeficiency syndrome.
He most often published in these fields:
- Virology (64.85%)
- Virus (46.76%)
- Antibody (23.89%)
What were the highlights of his more recent work (between 1991-2021)?
- Virology (64.85%)
- Virus (46.76%)
- Immunology (20.14%)
In recent papers he was focusing on the following fields of study:
Dani P. Bolognesi mainly focuses on Virology, Virus, Immunology, Gp41 and Peptide.
His Virology study incorporates themes from Antibody, Immunogenicity and Hiv transmission.
His Virus research incorporates themes from Cell culture and Immunopathology.
His Immunology study combines topics in areas such as Cytotoxic T cell and Acquired immunodeficiency syndrome.
Dani P. Bolognesi combines subjects such as Heptad repeat, Lipid bilayer fusion, Transmembrane protein, Molecular biology and Transmembrane glycoprotein with his study of Gp41.
As a member of one scientific family, Dani P. Bolognesi mostly works in the field of Peptide, focusing on Coiled coil and, on occasion, Leucine zipper.
Between 1991 and 2021, his most popular works were:
- POTENT SUPPRESSION OF HIV-1 REPLICATION IN HUMANS BY T-20, A PEPTIDE INHIBITOR OF GP41-MEDIATED VIRUS ENTRY (944 citations)
- A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. (512 citations)
- Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes (342 citations)
In his most recent research, the most cited papers focused on:
Dani P. Bolognesi spends much of his time researching Virology, Virus, Immunology, Antibody and Neutralizing antibody.
A large part of his Virology studies is devoted to Neutralization.
His research integrates issues of Peptide analog and HIV Protease Inhibitor in his study of Virus.
His studies in Immunology integrate themes in fields like Acquired immunodeficiency syndrome and Disease.
His work on Titer as part of general Antibody study is frequently linked to CXCR4, therefore connecting diverse disciplines of science.
His Neutralizing antibody research is multidisciplinary, incorporating elements of Vaccinia and Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
